Directors Holdings

    RNS Number : 8060G
  Meldex International PLC
  28 October 2008
   

 For Immediate Release  28 October 2008

    Meldex International plc

    ("Meldex", or "the Company")

    Directors' shareholding

    Following the issue of new ordinary shares earlier this month, the Company was informed that Helmut Kerschbaumer and Klaus Kuehne,
Interim CFO and COO respectively and Board Directors, have a beneficial interest, in 9.0%, of the issued share capital of the Company,
representing 21,041,139 ordinary shares in total.

    These shares are held by Melmed Holding AG ("Melmed") and Sanguisan GmbH (formerly Melbrosin GmbH - "Sanguisan"), which are entities in
which Helmut Kerschbaumer and Klaus Kuehne own substantial shareholdings. Melmed Holdings AG ("Melmed") owns 19,199,389 ordinary shares in
the Company while 1,841,750 ordinary shares are held by Sanguisan GmbH.

    The above shareholdings arose through the acquisition of the Melbrosin Group in June 2007 when 15,069,631 ordinary shares were issued as
vendor consideration, and 10,936,648 ordinary shares were subsequently issued in August 2008 to satisfy earn out obligations that arose in
respect of that acquisition. These shares were issued subject to lock in arrangements.  

    However the Board, (of which Helmut Kerschbaumer and Klaus Kuehne were not members at the time of the transactions), consented in
accordance with the provisions of the Sale and Purchase Agreement relating to the acquisition, to relax the lock in arrangements in respect
of 4,965,140 ordinary shares which were sold by Melmed and Sanguisan in November 2007 and May 2008. These shares were sold to meet tax and
other liabilities resulting from the sale of the Melbrosin Group. 

    The remaining shares held remain subject to lock in agreements in accordance with the Sale and Purchase Agreement as follows: 10,104,491
ordinary shares subject to lock-in until December 2008 and 10,936,648 subject to lock in until May 2009.

    The total number of shares in issue currently is 232,541,089. There are no shares are held in treasury. Therefore, the total number of
voting rights in the Company is 232,541,089. 





    For further information:

 Buchanan Communications  + 44 (0) 20 7466 5000
 Rebecca Skye Dietrich

 FinnCap, NOMAD           + 44 (0) 20 7600 1658
 Clive Carver 




This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
RDSPUGGUUUPRPGM